Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 581

1.

TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).

Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, et al.

Blood. 1995 May 15;85(10):2848-52.

2.

A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.

Murga Penas EM, Cools J, Algenstaedt P, Hinz K, Seeger D, Schafhausen P, Schilling G, Marynen P, Hossfeld DK, Dierlamm J.

Genes Chromosomes Cancer. 2003 May;37(1):79-83.

PMID:
12661008
3.
4.

Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13).

Yagasaki F, Jinnai I, Yoshida S, Yokoyama Y, Matsuda A, Kusumoto S, Kobayashi H, Terasaki H, Ohyashiki K, Asou N, Murohashi I, Bessho M, Hirashima K.

Genes Chromosomes Cancer. 1999 Nov;26(3):192-202.

PMID:
10502316
5.

Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.

Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, et al.

Oncogene. 1995 Apr 20;10(8):1511-9. Erratum in: Oncogene 1995 Aug 17;11(4):809.

PMID:
7731705
6.

Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes.

Raynaud SD, Baens M, Grosgeorge J, Rodgers K, Reid CD, Dainton M, Dyer M, Fuzibet JG, Gratecos N, Taillan B, Ayraud N, Marynen P.

Blood. 1996 Jul 15;88(2):682-9.

7.

TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.

Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, et al.

Blood. 1995 Aug 15;86(4):1525-33.

8.

Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene.

Yamamoto K, Nagata K, Yagasaki F, Tsurukubo Y, Tamura A, Taniwaki M, Hamaguchi H.

Cancer Genet Cytogenet. 2000 Jun;119(2):113-7. Review.

PMID:
10867145
9.

Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH.

Conchon M, McManus AP, Min T, Maljaie SH, Crawford A, Brito-Babapulle V, Matutes E, Catovsky D.

Cancer Genet Cytogenet. 1997 Jun;95(2):137-40.

PMID:
9169030
10.

A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.

Odero MD, Vizmanos JL, Román JP, Lahortiga I, Panizo C, Calasanz MJ, Zeleznik-Le NJ, Rowley JD, Novo FJ.

Genes Chromosomes Cancer. 2002 Sep;35(1):11-9.

PMID:
12203785
11.

All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N.

Blood. 1997 Jul 15;90(2):535-41.

12.

Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.

Tosi S, Hughes J, Scherer SW, Nakabayashi K, Harbott J, Haas OA, Cazzaniga G, Biondi A, Kempski H, Kearney L.

Genes Chromosomes Cancer. 2003 Oct;38(2):191-200.

PMID:
12939747
13.

Characterization of a t(10;12)(q24;p13) in a case of CML in transformation.

Aguiar RC, Chase A, Oscier DG, Carapeti M, Goldman JM, Cross NC.

Genes Chromosomes Cancer. 1997 Dec;20(4):408-11.

PMID:
9408758
14.

Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25).

Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, Asano S, Kamada N.

Blood. 1999 Feb 15;93(4):1355-63.

15.

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.

Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG.

Proc Natl Acad Sci U S A. 1995 May 23;92(11):4917-21.

16.

Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.

Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A.

Blood. 1997 Jul 15;90(2):571-7.

17.

Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies.

Wlodarska I, La Starza R, Baens M, Dierlamm J, Uyttebroeck A, Selleslag D, Francine A, Mecucci C, Hagemeijer A, Van den Berghe H, Marynen P.

Blood. 1998 Feb 15;91(4):1399-406.

18.

TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.

Kim DH, Moldwin RL, Vignon C, Bohlander SK, Suto Y, Giordano L, Gupta R, Fears S, Nucifora G, Rowley JD.

Blood. 1996 Aug 1;88(3):785-94.

19.

Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).

Yamamoto K, Nagata K, Tsurukubo Y, Inagaki K, Ono R, Taki T, Hayashi Y, Hamaguchi H.

Cancer Genet Cytogenet. 2002 Aug;137(1):64-7.

PMID:
12377416
20.

Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.

Zhang L, Parkhurst JB, Kern WF, Scott KV, Niccum D, Mulvihill JJ, Li S.

Chin Med J (Engl). 2003 Sep;116(9):1298-303.

PMID:
14527352
Items per page

Supplemental Content

Write to the Help Desk